Methionine metabolism controls the B cell EBV epigenome and viral latency.

dietary amino acid restriction folate metabolism gamma-herpesvirus immunometabolism lytic reactivation methionine cycle methionine metabolism one-carbon metabolism tumor virus viral latency

Journal

Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170

Informations de publication

Date de publication:
06 09 2022
Historique:
received: 20 02 2022
revised: 13 08 2022
accepted: 15 08 2022
entrez: 7 9 2022
pubmed: 8 9 2022
medline: 11 9 2022
Statut: ppublish

Résumé

Epstein-Barr virus (EBV) subverts host epigenetic pathways to switch between viral latency programs, colonize the B cell compartment, and reactivate. Within memory B cells, the reservoir for lifelong infection, EBV genomic DNA and histone methylation marks restrict gene expression. But this epigenetic strategy also enables EBV-infected tumors, including Burkitt lymphomas, to evade immune detection. Little is known about host cell metabolic pathways that support EBV epigenome landscapes. We therefore used amino acid restriction, metabolomic, and CRISPR approaches to identify that an abundant methionine supply and interconnecting methionine and folate cycles maintain Burkitt EBV gene silencing. Methionine restriction, or methionine cycle perturbation, hypomethylated EBV genomes and de-repressed latent membrane protein and lytic gene expression. Methionine metabolism also shaped EBV latency gene regulation required for B cell immortalization. Dietary methionine restriction altered murine Burkitt xenograft metabolomes and de-repressed EBV immunogens in vivo. These results highlight epigenetic/immunometabolism crosstalk supporting the EBV B cell life cycle and suggest therapeutic approaches.

Identifiants

pubmed: 36070681
pii: S1550-4131(22)00351-5
doi: 10.1016/j.cmet.2022.08.008
pmc: PMC9482757
mid: NIHMS1833895
pii:
doi:

Substances chimiques

Methionine AE28F7PNPL

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1280-1297.e9

Subventions

Organisme : NIDCR NIH HHS
ID : K99 DE031016
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI137337
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI164709
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA228700
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Cell Rep. 2014 Sep 11;8(5):1595-606
pubmed: 25159142
J Virol. 1998 Apr;72(4):2969-74
pubmed: 9525618
Nature. 2019 Aug;572(7769):397-401
pubmed: 31367041
J Virol. 2010 May;84(9):4534-42
pubmed: 20181711
Cell Metab. 2017 Jan 10;25(1):27-42
pubmed: 27641100
Nature. 2022 Mar;603(7900):321-327
pubmed: 35073561
Virology. 1991 Apr;181(2):595-608
pubmed: 1849678
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):16046-16055
pubmed: 31341086
PLoS Pathog. 2018 May 29;14(5):e1007070
pubmed: 29813138
PLoS Pathog. 2015 Mar 19;11(3):e1004656
pubmed: 25790223
Semin Cancer Biol. 2014 Jun;26:60-8
pubmed: 24457012
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Immun Inflamm Dis. 2021 Jun;9(2):351-362
pubmed: 33434416
Cold Spring Harb Symp Quant Biol. 2016;81:79-83
pubmed: 28174256
J Virol. 2019 Jun 14;93(13):
pubmed: 31019051
Cell Metab. 2019 Sep 3;30(3):539-555.e11
pubmed: 31257153
Mol Cell. 2016 Jan 21;61(2):210-21
pubmed: 26774282
Leukemia. 2021 Feb;35(2):377-388
pubmed: 32382081
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Database (Oxford). 2015 Jul 07;2015:bav067
pubmed: 26153137
Appl Microbiol. 1967 Jan;15(1):102-9
pubmed: 5298442
Science. 2022 Jan 21;375(6578):264-265
pubmed: 35025606
Science. 2022 Jan 21;375(6578):296-301
pubmed: 35025605
Blood. 2020 May 21;135(21):1870-1881
pubmed: 32157281
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Discov. 2015 Oct;5(10):1024-39
pubmed: 26382145
Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6
pubmed: 3033649
PLoS Pathog. 2019 Jun 21;15(6):e1007796
pubmed: 31226160
J Virol. 2006 Mar;80(5):2548-65
pubmed: 16474161
Microorganisms. 2021 Oct 21;9(11):
pubmed: 34835317
Nat Chem Biol. 2017 Jul;13(7):785-792
pubmed: 28553945
PLoS Pathog. 2010 Sep 23;6(9):e1001114
pubmed: 20886097
J Virol. 1989 Jul;63(7):3135-41
pubmed: 2470924
J Virol. 2017 Feb 14;91(5):
pubmed: 28003489
Nutr Cancer. 2002;42(2):158-66
pubmed: 12416254
Nat Commun. 2018 May 16;9(1):1955
pubmed: 29769529
Virology. 1977 Jan;76(1):152-63
pubmed: 189490
Nature. 2021 Feb;590(7844):157-162
pubmed: 33361812
Nat Rev Cancer. 2019 Nov;19(11):625-637
pubmed: 31515518
Front Genet. 2013 Apr 09;4:53
pubmed: 23577022
Nature. 2014 Jun 12;510(7504):298-302
pubmed: 24805240
Methods Mol Biol. 2019;1866:13-26
pubmed: 30725404
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11404-11409
pubmed: 29073064
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34161263
Cell Metab. 2014 May 6;19(5):780-94
pubmed: 24746804
Nat Rev Genet. 2020 Dec;21(12):737-753
pubmed: 32908249
Nat Microbiol. 2020 Aug;5(8):1051-1063
pubmed: 32424339
Cell. 2017 Apr 06;169(2):258-272.e17
pubmed: 28388410
J Virol. 2017 Sep 27;91(20):
pubmed: 28794029
J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002
pubmed: 2479717
Nat Cancer. 2020;1:653-664
pubmed: 33569544
iScience. 2020 Jan 24;23(1):100759
pubmed: 31887663
Eur J Immunol. 2021 Jan;51(1):64-75
pubmed: 32949466
Genes Dev. 2012 Jun 15;26(12):1326-38
pubmed: 22677546
PLoS Pathog. 2019 Sep 13;15(9):e1008030
pubmed: 31518366
Blood. 1998 Feb 15;91(4):1373-81
pubmed: 9454768
Eur J Clin Nutr. 2016 Mar;70(3):306-12
pubmed: 26395436
J Virol. 2018 Jan 2;92(2):
pubmed: 29118124
Cell Metab. 2020 Feb 4;31(2):250-266.e9
pubmed: 32023446
Annu Rev Immunol. 2015;33:787-821
pubmed: 25706097
Elife. 2019 Mar 27;8:
pubmed: 30916644
Cell Metab. 2012 Jul 3;16(1):9-17
pubmed: 22768835
J Biol Chem. 2002 Oct 11;277(41):38381-9
pubmed: 12161434
Prog Clin Biol Res. 1985;198:47-65
pubmed: 4070312
J Virol. 2019 Apr 3;93(8):
pubmed: 30700606
mBio. 2019 Sep 17;10(5):
pubmed: 31530670
Anticancer Res. 2022 Feb;42(2):641-644
pubmed: 35093861
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
EMBO Rep. 2021 Apr 7;22(4):e50128
pubmed: 33605073
Nat Rev Microbiol. 2008 Dec;6(12):913-24
pubmed: 19008891
Semin Cancer Biol. 2014 Jun;26:22-9
pubmed: 24468737
Physiol Rev. 2012 Oct;92(4):1515-42
pubmed: 23073625
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E782-90
pubmed: 26802124
Semin Cancer Biol. 1999 Oct;9(5):369-75
pubmed: 10547345
Science. 2017 Nov 10;358(6364):813-818
pubmed: 29123071
Viruses. 2020 Dec 01;12(12):
pubmed: 33271926
Mol Cell. 2020 May 21;78(4):653-669.e8
pubmed: 32315601
J Virol. 2000 Nov;74(22):10468-79
pubmed: 11044091
J Biol Chem. 2021 Jan-Jun;296:100547
pubmed: 33741341
J Virol. 2000 Aug;74(16):7610-8
pubmed: 10906215
J Gen Virol. 1990 Jul;71 ( Pt 7):1481-95
pubmed: 2165133
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893938
PLoS Pathog. 2021 Jan 26;17(1):e1009208
pubmed: 33497421
Cell Host Microbe. 2017 May 10;21(5):580-591.e7
pubmed: 28494239
Cell Rep. 2017 Dec 26;21(13):3819-3832
pubmed: 29281830
mBio. 2020 Oct 27;11(5):
pubmed: 33109754
mSphere. 2018 Nov 28;3(6):
pubmed: 30487153
Nat Methods. 2009 Apr;6(4):275-7
pubmed: 19305406
Semin Immunopathol. 2020 Apr;42(2):131-142
pubmed: 32232535
Curr Opin Virol. 2022 Feb;52:78-88
pubmed: 34891084
J Med Virol. 2021 Jun;93(6):3813-3823
pubmed: 32543727
Annu Rev Pathol. 2019 Jan 24;14:29-53
pubmed: 30125149
J Biol Chem. 2000 Sep 22;275(38):29318-23
pubmed: 10884384

Auteurs

Rui Guo (R)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Jin Hua Liang (JH)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Yuchen Zhang (Y)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Michael Lutchenkov (M)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Zhixuan Li (Z)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Yin Wang (Y)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

Vicenta Trujillo-Alonso (V)

Division of Pediatric Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USA.

Rishi Puri (R)

Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.

Lisa Giulino-Roth (L)

Division of Pediatric Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USA.

Benjamin E Gewurz (BE)

Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, 181 Longwood Avenue, Boston, MA 02115, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Harvard Program in Virology, Boston, MA 02115, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: bgewurz@bwh.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH